Myriad, AstraZeneca and Merck Expand Companion Diagnostic Partnership
Go back to Myriad, AstraZeneca and Merck Expand Companion Diagnostic Partnership| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 4.23 +0.22 (5.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.01 | 52 Week High | $45.34 | |||
| Open | $4.00 | 52 Week Low | $15.92 | |||
| Day High | $4.23 | P/E | 1.82 | |||
| Day Low | $3.97 | EPS | $2.33 | |||
| Volume | 671,959 | |||||
